Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Iowa Healthcare Reporter.
Press releases published on July 1, 2025
Cidara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
GlobeNewswire
·
July 1, 2025
SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company applying its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced that the Compensation and Human …
Goji Crazy for the Red, White & Blue Bowl at Frutta Bowls
GlobeNewswire
·
July 1, 2025
St. Petersburg, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Frutta Bowls, known for its specialty acai bowls and smoothies made with better-for-you ingredients, is turning up the flavor — and the fun — just in time for the Fourth of July. Starting today, all …
WeightWatchers and Novo Nordisk Expand Collaboration to Improve Medication Access Through Trusted, Holistic Model of Care
GlobeNewswire
·
July 1, 2025
WeightWatchers Clinic Members Can Access FDA-Approved Wegovy® for $299 in July, a $200 Savings Offer to Improve Access as WeightWatchers’ Trusted, Science-Backed Approach Continues to Lead the Industry Collaboration Builds a Seamless NovoCare® Pharmacy …
Vireo Growth Inc. and Curio Wellness Announce Manufacturing and Distribution Partnership
GlobeNewswire
·
July 1, 2025
-- Leading cannabis companies partner to leverage existing IP and brand value in New York -- CHICAGO and MINNEAPOLIS, July 01, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (“Vireo” or the “Company”) (CSE: VREO; OTCQX: VREOF), a multi-state, vertically- …
Serina Therapeutics Announces Date for 2025 Annual Stockholders Meeting
GlobeNewswire
·
July 1, 2025
HUNTSVILLE, July 01, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company, today announced that its Board of Directors has established November 7, 2025, as the date of its 2025 annual …
Lixte Biotechnology Holdings, Inc. Announces $5.0 Million Private Placement Priced at the Market
GlobeNewswire
·
July 1, 2025
PASADENA, CALIF, July 01, 2025 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the “Company”), a clinical stage pharmaceutical company, today announced that, on June 30, 2025 intraday, it entered into a definitive agreement with …
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 1, 2025
NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara” or the “Company”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the recent …
Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025
GlobeNewswire
·
July 1, 2025
SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2025 on Thursday, July 31, 2025, after the New York Stock Exchange closes. …
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 1, 2025
CAMBRIDGE, Mass., July 01, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted four newly-hired employees options to purchase an …
ArriVent Announces Proposed $75 Million Public Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire
·
July 1, 2025
NEWTOWN SQUARE, Pa., July 01, 2025 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (“ArriVent”) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced that it …
Cue Biopharma Provides Update on Most Advanced Clinical Stage Asset, CUE-101, Presented by Dr. Dimitrios Colevas at the DAVA 4th Hawaii Global Summit on Thoracic Malignancies
GlobeNewswire
·
July 1, 2025
ORR of 50% in treatment-naïve patients with HPV+ R/M HNSCC 12-month landmark survival of 88% and mOS of 32 months BOSTON, July 01, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel …
Vor Bio Report Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
July 1, 2025
CAMBRIDGE, Mass., July 01, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, effective as of June 26, 2025, the Board of Directors granted Jean- …
Effective Testosterone Booster for Men Over 50: TestoPrime Medically Accredited as the Best Testosterone Supplement for Males In 40's and 50's
GlobeNewswire
·
July 1, 2025
New York City, NY, July 01, 2025 (GLOBE NEWSWIRE) -- For men in their 40s and 50s seeking a proven, safe, and powerful way to restore youthful energy, muscle, and vitality, a breakthrough solution has arrived. TestoPrime, the most effective testosterone …
Paroxysmal Nocturnal Hemoglobinuria Market Set for Robust Growth During the Forecast Period (2025–2034) Owing to the Advancements in Complement Inhibitor Therapies | DelveInsight
GlobeNewswire
·
July 1, 2025
New York, USA, July 01, 2025 (GLOBE NEWSWIRE) -- Paroxysmal Nocturnal Hemoglobinuria Market Set for Robust Growth During the Forecast Period (2025–2034) Owing to the Advancements in Complement Inhibitor Therapies | DelveInsight The paroxysmal nocturnal …
ProKidney Corp. Completes Domestication from the Cayman Islands to Delaware
GlobeNewswire
·
July 1, 2025
WINSTON-SALEM, N.C., July 01, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced the completion of the …
CMI Media Group kündigt Event „Agility Berlin 2025“ an; Martin Strobel hält Keynote-Rede
GlobeNewswire
·
July 1, 2025
LONDON, July 01, 2025 (GLOBE NEWSWIRE) -- Die strategische Medienagentur für das Gesundheitswesen CMI Media Group, ein Unternehmen der WPP (NYSE: WPP), freut sich, den ersten europäischen Event Agility Berlin: Transformative Thinking, Rx Precision in …
CMI Media Group annonce l’événement Agility Berlin 2025 ; Martin Strobel y tiendra le rôle de conférencier principal
GlobeNewswire
·
July 1, 2025
LONDRES, 01 juill. 2025 (GLOBE NEWSWIRE) -- L’agence stratégique spécialisée dans les médias de santé CMI Media Group, une société du groupe WPP (NYSE : WPP), est fière d’annoncer la tenue du premier événement européen « Agility Berlin: Transformative …
Foundation for Sarcoidosis Research Announces Launch of Enhanced Sarcoidosis Data Registry
GlobeNewswire
·
July 1, 2025
CHICAGO, July 01, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR), the leading international organization dedicated to finding a cure for sarcoidosis and improving care for those affected, is proud to announce the launch of a new and …
BioNTX Expands 2025 Tech Transfer Showcase to Spotlight Regional Innovation and Collaboration
GlobeNewswire
·
July 1, 2025
DALLAS, July 01, 2025 (GLOBE NEWSWIRE) -- BioNTX, the premier trade organization for biotechnology and healthcare innovation in North Texas, is proud to announce the expansion of its 4th annual Tech Transfer Showcase, a cornerstone of the highly …
CMI Media Group Announces 2025 Agility Berlin Event; Martin Strobel to Keynote
GlobeNewswire
·
July 1, 2025
LONDON, July 01, 2025 (GLOBE NEWSWIRE) -- Strategic media healthcare agency CMI Media Group, a WPP company (NYSE: WPP), is proud to announce the inaugural European event, Agility Berlin: Transformative Thinking, Rx Precision in Healthcare Marketing, …